373 related articles for article (PubMed ID: 33639890)
1. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
[TBL] [Abstract][Full Text] [Related]
2. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic characteristics and prognostic analysis of monoclonal gammopathy of renal significance (MGRS) in patients with IgM monoclonal gammopathy: a case series.
Liu J; Liang D; Liang S; Xu F; Huang X; Jiang S; Hou J
Sci Rep; 2022 Oct; 12(1):16994. PubMed ID: 36216844
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review.
Yu H; He D; Zhang Q; Cao B; Liu W; Wu Y
Front Oncol; 2022; 12():914379. PubMed ID: 35912259
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy.
Wang M; Lei L; Chen H; Di L; Pang M; Lu Y; Lu L; Shen XM; Da Y
Neuromuscul Disord; 2017 Oct; 27(10):942-946. PubMed ID: 28606401
[TBL] [Abstract][Full Text] [Related]
7. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
8. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen.
Kumutpongpanich T; Owattanapanich W; Tanboon J; Nishino I; Boonyapisit K
Neuromuscul Disord; 2018 Jul; 28(7):610-613. PubMed ID: 29910095
[TBL] [Abstract][Full Text] [Related]
9. Interstitial amyloidosis in sporadic inclusion body myositis.
Alamr M; Milone M; Naddaf E; Ytterberg SR; Steel SJ; Jones LK; Liewluck T
Muscle Nerve; 2021 Nov; 64(5):590-594. PubMed ID: 34196979
[TBL] [Abstract][Full Text] [Related]
10. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
11. [Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance mimicking POEMS syndrome].
Kanamori T; Kusumoto S; Okita K; Hagiwara S; Kato C; Nakashima T; Murakami S; Narita T; Ito A; Ri M; Ishida T; Komatsu H; Matsukawa N; Iida S
Rinsho Ketsueki; 2018; 59(2):161-166. PubMed ID: 29515067
[TBL] [Abstract][Full Text] [Related]
12. A case of sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: long-term observation of neurological symptoms after autologous stem-cell transplantation.
Ando T; Sato T; Kurahashi S; Kawaguchi Y; Kagaya Y; Ozawa Y; Hirano S; Goto Y; Mano K; Yokoi S; Nakamura T; Murakami A; Noda S; Kimura S; Sone J; Kuru S; Sobue G; Katsuno M
Nagoya J Med Sci; 2021 Aug; 83(3):641-647. PubMed ID: 34552296
[TBL] [Abstract][Full Text] [Related]
13. IgG,kappa monoclonal gammopathy of unknown significance with AL amyloidosis simulating giant cell arteritis.
Pompilian VM; Tănăseanu Ş; Badea C; Zurac S; Socoliuc C; Badelita S; Botez E; Antohe M
Rom J Intern Med; 2017 Sep; 55(3):179-182. PubMed ID: 28467313
[TBL] [Abstract][Full Text] [Related]
14. Treatment-responsive glycogen storage myopathy in a patient with POEMS syndrome: A new monoclonal gammopathy-associated myopathy.
Soontrapa P; Tracy JA; Gonsalves WI; Liewluck T
Eur J Neurol; 2023 Oct; 30(10):3404-3406. PubMed ID: 37522432
[TBL] [Abstract][Full Text] [Related]
15. Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy - incidental or related?
Moshe-Lilie O; Banks G; Medvedova E; Masri A; Chahin N
Neuromuscul Disord; 2022 Jun; 32(6):533-538. PubMed ID: 35550111
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
[TBL] [Abstract][Full Text] [Related]
17. Diffuse Peritoneal and Bowel Wall Infiltration by Light Chain-AL Amyloidosis with Omental Calcification Mimicking Abdominal Carcinomatosis - An Elderly Female with Incidental Finding of Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
Junejo S; Ali Y; Singh Lubana S; Tuli SS
Am J Case Rep; 2017 Nov; 18():1247-1250. PubMed ID: 29176541
[TBL] [Abstract][Full Text] [Related]
18. Incidentally Detected Amyloid Light-Chain Amyloidosis Caused by Monoclonal Gammopathy of Undetermined Significance: Possible Time-Dependent Change in Colonic Findings.
Fukui T; Tanimura Y; Matsumoto Y; Horitani S; Tomiyama T; Okazaki K
Case Rep Gastroenterol; 2018; 12(3):737-746. PubMed ID: 30631261
[TBL] [Abstract][Full Text] [Related]
19. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
20. [More than 10 years of complete remission of monoclonal gammopathy of undetermined significance and cessation of light chain deposition disease-associated nephrotic syndrome following treatment with vincristine, adriamycin and high-dose dexamethasone (VAD)].
Adam Z; Nedbálková M; Krejcí M; Pour L; Husek K; Veselý K; Cermáková Z; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Mar; 56(3):240-6. PubMed ID: 20394211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
